Justin J. McAnear - Jun 1, 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Chief Financial Officer
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol: TXG
Transactions as of: Jun 1, 2021
Transactions value $: -$1,693,669
Form type: 4
Date filed: 6/3/2021, 06:51 PM
Previous filing: May 26, 2021
Next filing: Jul 6, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Options Exercise	$50.4K	+10K	+25.63%	$5.04^*	49K	Jun 1, 2021	Direct	F1
transaction	TXG	Class A Common Stock	Sale	-$429K	-2.5K	-5.1%	$171.59	46.5K	Jun 1, 2021	Direct	F1, F2
transaction	TXG	Class A Common Stock	Sale	-$138K	-800	-1.72%	$172.85	45.7K	Jun 1, 2021	Direct	F1, F3
transaction	TXG	Class A Common Stock	Sale	-$174K	-1K	-2.19%	$173.94	44.7K	Jun 1, 2021	Direct	F1, F4
transaction	TXG	Class A Common Stock	Sale	-$349K	-1.99K	-4.46%	$174.93	42.7K	Jun 1, 2021	Direct	F1, F5
transaction	TXG	Class A Common Stock	Sale	-$511K	-2.91K	-6.8%	$175.77	39.8K	Jun 1, 2021	Direct	F1, F6
transaction	TXG	Class A Common Stock	Sale	-$53.4K	-300	-0.75%	$178.07	39.5K	Jun 1, 2021	Direct	F1, F7
transaction	TXG	Class A Common Stock	Sale	-$35.8K	-200	-0.51%	$179.21	39.3K	Jun 1, 2021	Direct	F1, F8
transaction	TXG	Class A Common Stock	Sale	-$54K	-300	-0.76%	$180.02	39K	Jun 1, 2021	Direct	F1, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Options Exercise	$0	-10K	-2.32%	$0.00	420K	Jun 1, 2021	Class A Common Stock	10K	$5.04	Direct	F1, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2	This transaction was executed in multiple trades at prices ranging from $171.12 to $172.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3	This transaction was executed in multiple trades at prices ranging from $172.25 to $173.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4	This transaction was executed in multiple trades at prices ranging from $173.36 to $174.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5	This transaction was executed in multiple trades at prices ranging from $174.38 to $175.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6	This transaction was executed in multiple trades at prices ranging from $175.42 to $176.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7	This transaction was executed in multiple trades at prices ranging from $177.65 to $178.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8	This transaction was executed in multiple trades at prices ranging from $178.92 to $179.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9	This transaction was executed in multiple trades at prices ranging from $179.97 to $180.10. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10	This option, originally for 600,000 shares, of which 179,841 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.